New experimental vaccine for Lou Gehrig's disease gets EU funding

5 (84) ·

$ 7.99 ·

In stock

Description

Navy Officer Fights for Right to Try Unproven Drugs Before Dying

Intravacc and DZNE awarded EU funding to develop vaccine against

ex99-2_006.jpg

ALS patients contend with $158,000 price tag on new drug

The Dish's Weekly News Wrap Up - March 22, 2013

ALS in 2022: most anticipated drug trial results

Amyloid Oligomers: A Joint Experimental/Computational Perspective

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised

A brief history of ALS awareness and its sparse treatments

Fall 2022 Magazine Wallace H. Coulter Department of Biomedical

Most Experimental Drugs are Tested Offshore–Raising Concerns about

JPM, Free Full-Text

RNA Drugs and RNA Targets for Small Molecules: Principles

Stem Cells: ALS Treatment Breakthrough (2023)